Cash and Cash Equivalents, at Carrying Value of BIOADAPTIVES, INC. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
BIOADAPTIVES, INC. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • BIOADAPTIVES, INC. Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Dec 2024 was $261,885, a 196% increase year-over-year.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

BIOADAPTIVES, INC. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $261,885 +$173,328 +196% 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q4 2023 $88,557 +$5,621 +6.8% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q4 2022 $82,936 $0 0% 31 Dec 2022 10-K 10 Apr 2024 2023 FY
Q3 2022 $17,909 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q4 2021 $82,936 +$78,349 +1708% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q1 2021 $24,226 +$12,577 +108% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $4,587 -$7,726 -63% 31 Dec 2020 10-Q 14 May 2021 2021 Q1
Q3 2020 $14,449 +$14,294 +9222% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $3,999 -$7,867 -66% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $11,649 -$7,670 -40% 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q4 2019 $12,313 -$43,902 -78% 31 Dec 2019 10-Q 14 May 2021 2021 Q1
Q3 2019 $155 30 Sep 2019 10-Q 16 Nov 2020 2020 Q3
Q2 2019 $11,866 -$168,645 -93% 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $19,319 31 Mar 2019 10-Q/A 11 Jun 2020 2020 Q1
Q4 2018 $56,215 +$55,855 +15515% 31 Dec 2018 10-K 30 Mar 2021 2020 FY
Q2 2018 $180,511 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q4 2017 $360 31 Dec 2017 10-Q 14 Aug 2019 2019 Q2
Q3 2016 $11,949 +$11,787 +7276% 30 Sep 2016 10-Q 18 Nov 2016 2016 Q3
Q2 2016 $100 -$11,900 -99% 30 Jun 2016 10-Q 18 Aug 2016 2016 Q2
Q1 2016 $139 -$2,615 -95% 31 Mar 2016 10-Q 23 May 2016 2016 Q1
Q4 2015 $99 -$37,772 -100% 31 Dec 2015 10-Q 18 Nov 2016 2016 Q3
Q3 2015 $162 -$37,751 -100% 30 Sep 2015 10-Q 18 Nov 2016 2016 Q3
Q2 2015 $12,000 +$4,542 +61% 30 Jun 2015 10-Q 18 Aug 2016 2016 Q2
Q1 2015 $2,754 -$8,787 -76% 31 Mar 2015 10-Q 23 May 2016 2016 Q1
Q4 2014 $37,871 +$19,262 +104% 31 Dec 2014 10-Q 18 Nov 2016 2016 Q3
Q3 2014 $37,913 30 Sep 2014 10-Q 23 Nov 2015 2015 Q3
Q2 2014 $7,458 30 Jun 2014 10-Q 21 Aug 2015 2015 Q2
Q1 2014 $11,541 31 Mar 2014 10-Q 20 May 2015 2015 Q1
Q4 2013 $18,609 31 Dec 2013 10-K 14 Apr 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.